Convalescent plasma for COVID-19. A randomized clinical trial

…, JG den Hollander, F Karim, FPN Mollema… - MEDRxiv, 2020 - medrxiv.org
Structured abstract for full paper Background After recovery from COVID-19, most patients
have anti-SARS-CoV-2 neutralizing antibodies. Their convalescent plasma could be an …

[HTML][HTML] Effects of potent neutralizing antibodies from convalescent plasma in patients hospitalized for severe SARS-CoV-2 infection

…, JG den Hollander, F Karim, FPN Mollema… - Nature …, 2021 - nature.com
In a randomized clinical trial of 86 hospitalized COVID-19 patients comparing standard care
to treatment with 300mL convalescent plasma containing high titers of neutralizing SARS-…

5 years of experience implementing a methicillin-resistant Staphylococcus aureus search and destroy policy at the largest university medical center in the Netherlands

…, MD Behrendt, DC Melles, FPN Mollema… - Infection Control & …, 2009 - cambridge.org
Objective.TO evaluate the effectiveness of a rigorous search and destroy policy for
controlling methicillin-resistant Staphylococcus aureus (MRSA) infection or colonization.Design.…

Significant impact of coronavirus disease 2019 (COVID-19) on human immunodeficiency virus (HIV) care in hospitals affecting the first pillar of the HIV care continuum

…, JJA van Kampen, FPN Mollema… - Clinical Infectious …, 2022 - academic.oup.com
During COVID-19 lockdown, the in-hospital number of HIV indicator conditions decreased
disproportionally compared with other non–COVID-19 diseases, which was accompanied by …

[HTML][HTML] Rapid Response to Remdesivir in Hospitalised COVID-19 Patients: A Propensity Score Weighted Multicentre Cohort Study

…, NM Delfos, M van der Feltz, FPN Mollema… - Infectious Diseases and …, 2023 - Springer
Introduction Remdesivir is a registered treatment for hospitalised patients with COVID-19
that has moderate clinical effectiveness. Anecdotally, some patients’ respiratory insufficiency …

An unusual case of congestive heart failure in the Netherlands

…, OC Manintveld, FPN Mollema… - JMM Case …, 2018 - microbiologyresearch.org
Introduction. Chagas disease is caused by infection with the protozoan Trypanosoma cruzi.
It is endemic to the American continent due to the distribution of its insect vectors. The …

Effectiveness of different antimicrobial strategies for staphylococcal prosthetic joint infection: results from a large prospective registry-based cohort study

…, LBS Gelinck, FPN Mollema… - Open Forum …, 2022 - academic.oup.com
Background Treatment of staphylococcal prosthetic joint infection (PJI) usually consists of
surgical debridement and prolonged rifampicin combination therapy. Tailored antimicrobial …

Significant impact of COVID-19 on HIV care in hospitals affecting the first pillar of the HIV care continuum

…, JJA van Kampen, FPN Mollema… - … Diseases: An Official …, 2021 - ncbi.nlm.nih.gov
During COVID-19 lockdown, the in-hospital number of HIV indicator conditions decreased
disproportionally compared to other non-COVID-19 diseases which was accompanied by …

[PDF][PDF] … , Nathalie M. Delfos, Joris CT van der Lugt, Karin Ellen Veldkamp, Peter A. Nolte, Masja Leendertse, Luc BS Gelinck, Femke PN Mollema, Emile F. Schippers …

G Wattel-Louis, LG Visser… - Prosthetic joint …, 2022 - scholarlypublications …
Conclusions A short-term rifampicin strategy with either clindamycin or flucloxacillin and
only five days of rifampicin was found to be as effective as traditional long-term rifampicin …

[BOOK][B] Clinical Epidemiological Studies on Methicillin Resistant and Suscepti ble Staphylococci

F Mollema - 2009 - repub.eur.nl
__Abstract__ Staphylococcus aureus was discovered for the fi rst ti me in the 1880s [1].
Since then, S. aureus has been shown to be a major pathogenic Gram-positi ve bacterium, …